investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Jerald Patrick Radich

The Genetics of Post-Transplant Relapse in Myeloid Malignancy

Leukaemia

Pathology

Ann Mullally

Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells

Leukaemia

Christopher Y Park

Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia

Leukaemia

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Leukaemia

Gerd P Pfeifer

5-hydroxymethylcytosine in Human Cancer

Leukaemia

Andrew A Lane

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Leukaemia

Soheil Meshinchi

Biology and Prognostic Implications of FLT3 Mutations in AML

Leukaemia

George A Calin

Protein-coding and non-coding RNA biomarkers for early detection of CLL

Leukaemia

James Kochenderfer

Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor

Leukaemia

Hematology and hematologic malignancies